Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
- Guggenheim Healthcare Talks |
Idea Forum | Neuro/Immunology Day onMonday, November 18, 2019 ;
- Stifel 2019 Healthcare Conference on
Tuesday, November 19, 2019 at3:35 pm ET ; and
- Jefferies 2019
London Healthcare Conference onThursday, November 21, 2019 at4:00 pm GMT .
The above listed dates and times are subject to change. Details on company presentations and webcasts can be found on the “Investors” section of Xenon's website at www.xenon-pharma.com. All webcasts will be posted for replay following the event for 30 days.
About
We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered trademarks or trademarks of
Investor/Media Contact:
Phone: 604.484.3353
Email: investors@xenon-pharma.com
Source: Xenon Pharmaceuticals Inc.